Emerging technologies & innovation systems

A disruptive or path-breaking innovation can deliver remarkable advances in healthcare, agriculture, energy, transport and financial services but innovators in these areas are also faced with great uncertainty around the nature of future business models and value chains. Innogen offers new insights and methodological approaches for foresighting future business models and value chains in the context of an innovation ecosystem that can either support or constrain the eventual market availability of the technology. Innogen’s expertise lies in understanding, assessing and supporting this innovation-led growth.

Projects

Professor Alan Raybould (1963-2022)

17 October 2022

We are deeply saddened to learn of the passing of Alan Raybould, Chair in Innovation in the Life Sciences at the University of Edinburgh and Innogen co-director.

Innogen welcomes Alan Raybould

23 August 2019

Prof. Alan Raybould joins the University of Edinburgh as Chair of Innovation in the Life Sciences.

Meet our Researchers: Dr Katie Adam

20 February 2020

We speak with Dr Katie Adam, a Postdoctoral Research Fellow working on interdisciplinary animal health projects. She trained as a veterinary surgeon at the Royal (Dick) School of Veterinary Studies in Edinburgh and holds a master’s degree in Aquatic Medicine from the Norwegian School of Veterinary Science. Before joining Innogen, she worked in clinical veterinary practice and as a field epidemiologist, researching endemic animal diseases. 

Predicting COVID-19 vaccine success

8 October 2020

Innogen Associate, Dr Jack Scannell, has co-authored a policy paper for the Centre for Global Development that analyses the COVID-19 vaccine pipeline. This work aims to bring high-quality probabilistic models of the COVID-19 vaccine pipeline into the public domain, to help policy development as well as the management of technological and manufacturing risks.  

Industry-wide standard supports companies to innovate responsibly

4 February 2021

Innogen Masters students trial the application of the British Standards Institution (BSI) Responsible Innovation Guide, PAS 440, in two early-stage biotechnology companies.